Abstract
Tobacco use and dependence remains the number one preventable cause of disease and death. While smoking rates have dropped significantly over the past 50 years, they remain high in certain populations, including those with serious mental health conditions and in low-income and low-education populations. Patients may utilize multiple forms of tobacco, including cigarettes, cigars, smokeless tobacco, and electronic nicotine delivery systems (also called e-cigarettes or vapes). Tobacco use causes or contributes to many chronic diseases, and tobacco dependence is considered a chronic disease itself. Tobacco cessation counseling, even if brief, significantly improves cessation outcomes. Successful cessation often requires repeated intervention and multiple attempts to quit. The Chronic Care Model can improve health outcomes through system changes and a population health approach to support patient-centered and evidence-based care, including team-based care, planned interventions, self-management tools, telehealth, connection to community resources, integrated decision support, patient registries, information technology supports, and quality improvement initiatives. A comprehensive tobacco control program includes policy enactment and enforcement, including effective clean air policies, higher taxes on tobacco products, media campaigns, marketing and tobacco access restrictions, and access to treatment services.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
U.S. Department of Health and Human Services. Smoking cessation: a report of the surgeon general; 2020. https://www.hhs.gov/surgeongeneral/reports-and-publications/tobacco/2020-cessation-sgr-factsheet-key-findings/index.html. Accessed 01 Jul 2020
Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults—United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71:397–405. https://doi.org/10.15585/mmwr.mm7111a1external.
Reitsma MB, Kendrick PJ, Ababneh E, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the global burden of disease study 2019. Lancet. 2021;397(10292):2337–60. https://doi.org/10.1016/s0140-6736(21)01169-7.
Jacobs EJ, Newton CC, Carter BD, et al. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol. 2015;25(3):179–82. e1. https://doi.org/10.1016/j.annepidem.2014.11.008.
Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54. https://doi.org/10.3322/caac.21440.
The health consequences of smoking—50 years of progress: a report of the surgeon general; 2014.
The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general; 2006.
Meernik C, Goldstein AO. A critical review of smoking, cessation, relapse and emerging research in pregnancy and post-partum. Br Med Bull Jun 2015;114(1):135–146. doi:https://doi.org/10.1093/bmb/ldv016.
Xu X, Shrestha SS, Trivers KF, Neff L, Armour BS, King BA. U.S. healthcare spending attributable to cigarette smoking in 2014. Prev Med. 2021:106529. https://doi.org/10.1016/j.ypmed.2021.106529.
Shrestha SS, Ghimire R, Wang X, Trivers KF, Homa DM, Armour BS. Cost of cigarette smoking attributable productivity losses, U.S., 2018. Am J Prev Med. 2022; https://doi.org/10.1016/j.amepre.2022.04.032.
Max W, Sung HY, Shi Y. Deaths from secondhand smoke exposure in the United States: economic implications. Am J Public Health. 2012;102(11):2173–80. https://doi.org/10.2105/AJPH.2012.300805.
Stanton CA, Keith DR, Gaalema DE, et al. Trends in tobacco use among US adults with chronic health conditions: National Survey on drug use and health 2005-2013. Prev Med. 2016;92:160–8. https://doi.org/10.1016/j.ypmed.2016.04.008.
Kong AY, Queen TL, Golden SD, Ribisl KM. Neighborhood disparities in the availability, advertising, promotion, and youth appeal of little cigars and cigarillos, United States, 2015. Nicotine Tob Res. 2020;22(12):2170–7. https://doi.org/10.1093/ntr/ntaa005.
Edwards SA, Bondy SJ, Callaghan RC, Mann RE. Prevalence of unassisted quit attempts in population-based studies: a systematic review of the literature. Addict Behav. 2014;39(3):512–9. https://doi.org/10.1016/j.addbeh.2013.10.036.
Danesh D, Paskett ED, Ferketich AK. Disparities in receipt of advice to quit smoking from health care providers: 2010 National Health Interview Survey. Prev Chronic Dis. 2014;11:E131. https://doi.org/10.5888/pcd11.140053.
Fiore M, Jaen CR, Baker T, et al. Treating tobacco use and dependence: 2008 update. Rockville, MD: US Department of Health and Human Services; 2008.
Creamer MR, Wang TW, Babb S, et al. Tobacco product use and cessation indicators among adults-United States, 2018. MMWR. 2019;68(45):1013–9.
Heyman GM. Do addicts have free will? An empirical approach to a vexing question. Addict Behav Rep Jun 2017;5:85–93. doi:https://doi.org/10.1016/j.abrep.2017.02.001.
Lemmens VOA, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prevention. 2008;17(6):535–44. https://doi.org/10.1097/CEJ.0b013e3282f75e48.
Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008;148(7):554–6.
Halladay JR, Vu M, Ripley-Moffitt C, Gupta SK, O’Meara C, Goldstein AO. Patient perspectives on tobacco use treatment in primary care. Prev Chronic Dis. 2015;12:E14. https://doi.org/10.5888/pcd12.140408.
Gritz ER, Vidrine DJ, Fingeret MC. Smoking cessation: a critical component of medical management in chronic disease populations. Am J Prev Med. 2007;33(6):S414–22.
Rojewski AM, Baldassarri S, Cooperman NA, et al. Exploring issues of comorbid conditions in people who smoke. Nicotine Tob Res. 2016;18(8):1684–96. https://doi.org/10.1093/ntr/ntw016.
Reis RK, Miller SC. The ASAM principles of addiction medicine. Wolters Kluwer Health; 2014.
Berridge MS, Apana SM, Nagano KK, Berridge CE, Leisure GP, Boswell MV. Smoking produces rapid rise of [11C]nicotine in human brain. Psychopharmacology. 2010;209(4):383–94. https://doi.org/10.1007/s00213-010-1809-8.
Byron MJ, Baig SA, Moracco KE, Brewer NT. Adolescents’ and adults’ perceptions of ‘natural’, ‘organic’ and ‘additive-free’ cigarettes, and the required disclaimers. Tob Control. 2016;25(5):517. https://doi.org/10.1136/tobaccocontrol-2015-052560.
Commission USFT. U.S. Federal Trade Commission (FTC), Cigarette Report for 2020, 2021. 2021.
Levy DT, Blackman K, Tauras J, et al. Quit attempts and quit rates among menthol and nonmenthol smokers in the United States. Am J Public Health. 2011;101(7):1241–7. https://doi.org/10.2105/ajph.2011.300178.
Keeler C, Max W, Yerger V, Yao T, Ong MK, Sung HY. The association of menthol cigarette use with quit attempts, successful cessation, and intention to quit across racial/ethnic groups in the United States. Nicotine Tob Res. 2016; https://doi.org/10.1093/ntr/ntw215.
FDA proposes rules prohibiting menthol cigarettes and Flavored cigars to prevent youth initiation, significantly reduce tobacco-related disease and death. FDA; 04/28/2022. https://www.fda.gov/news-events/press-announcements/fda-proposes-rules-prohibiting-menthol-cigarettes-and-flavored-cigars-prevent-youth-initiation
Office on Smoking and Health NCfCDPaHP. Hookahs. U.S. Department of Health & Human Services; 2022. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/tobacco_industry/hookahs/index.htm. Accessed 29 Aug 2022.
General USPHSOotS, Prevention NCfCD, Smoking HPOo. Preventing tobacco use among youth and young adults: a report of the surgeon general. US Government Printing Office; 2012.
Biener L, Nyman AL, Stepanov I, Hatsukami D. Public education about the relative harm of tobacco products: an intervention for tobacco control professionals. Tob Control. 2014;23(5):385. https://doi.org/10.1136/tobaccocontrol-2012-050814.
Organization WH. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 89: smokeless tobacco and some tobacco-specific N-nitrosamines; 2007.
Prevention UCfDCa. Smokeless tobacco: health effects. Office on Smoking and Health, US Center for Disease Control and Prevention. Updated August 13, 2020. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/health_effects/index.htm. Accessed 9 Sep 2022.
Burton A. Does the smoke ever really clear? Thirdhand smoke exposure raises new concerns. Environ Health Perspect. 2011;119(2):A70–4.
Protano C, Vitali M. The new danger of thirdhand smoke: why passive smoking does not stop at secondhand smoke. Environ Health Perspect. 2011;119(10):A422. https://doi.org/10.1289/ehp.1103956.
Diez-Izquierdo A, Cassanello-Penarroya P, Lidon-Moyano C, Matilla-Santander N, Balaguer A, Martinez-Sanchez JM. Update on thirdhand smoke: a comprehensive systematic review. Environ Res. 2018;167:341–71. https://doi.org/10.1016/j.envres.2018.07.020.
U.S. Department of Health and Human Services. America’s health rankings analysis of National Survey of Children’s Health. (MCHB) MaCHB; 2021. https://www.americashealthrankings.org. Accessed 15 Sep 2022
CDC. Vital signs: nonsmokers’ exposure to secondhand smoke—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2010;59(35):1141–6.
Northrup TF, Matt GE, Hovell MF, Khan AM, Stotts AL. Thirdhand smoke in the homes of medically fragile children: assessing the impact of indoor Smoking levels and Smoking bans. Nicotine Tob Res. 2016;18(5):1290–8. https://doi.org/10.1093/ntr/ntv174.
Bahl V, Jacob P 3rd, Havel C, Schick SF, Talbot P. Thirdhand cigarette smoke: factors affecting exposure and remediation. PLoS One. 2014;9(10):e108258. https://doi.org/10.1371/journal.pone.0108258.
Hang B, Sarker AH, Havel C, et al. Thirdhand smoke causes DNA damage in human cells. Mutagenesis. 2013;28(4):381–91. https://doi.org/10.1093/mutage/get013.
Rehan VK, Sakurai R, Torday JS. Thirdhand smoke: a new dimension to the effects of cigarette smoke on the developing lung. Am J Physiol Lung Cell Mol Physiol. 2011;301(1):L1–8. https://doi.org/10.1152/ajplung.00393.2010.
Díez-Izquierdo A, Cassanello-Peñarroya P, Lidón-Moyano C, Matilla-Santander N, Balaguer A, Martínez-Sánchez JM. Update on thirdhand smoke: a comprehensive systematic review. Environ Res. 2018;167:341–71. https://doi.org/10.1016/j.envres.2018.07.020.
Klein JD, Chamberlin ME, Kress EA, et al. Asking the right questions about secondhand smoke. Nicotine Tob Res. 2021;23(1):57–62. https://doi.org/10.1093/ntr/ntz125.
ICD10.Data.com. ICD10-CM Codes. https://www.icd10data.com/ICD10CM/Codes/Z00-Z99/Z77-Z99/Z77-/Z77.22. Accessed 29 Aug 2022.
Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–50. https://doi.org/10.1056/NEJMsa1211128.
Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008;6(6):883–95. https://doi.org/10.1586/14779072.6.6.883.
Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29.
Robbins AS, Manson JE, Lee IM, Satterfield S, Hennekens CH. Cigarette smoking and stroke in a cohort of U.S. male physicians. Ann Intern Med. 1994;120(6):458–62.
McRobbie H, Hajek P. Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction. 2001;96(11):1547–51. https://doi.org/10.1080/09652140120080688.
Barth J, Critchley J, Bengel J. Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis. Ann Behav Med. 2006;32(1):10–20. https://doi.org/10.1207/s15324796abm3201_2.
Mikhailidis DP, Papadakis JA, Ganotakis ES. Smoking, diabetes and hyperlipidaemia. J R Soc Health. 1998;118(2):91–3.
Becker RH, Sha S, Frick AD, Fountaine RJ. The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care. 2006;29(2):277–82.
Tonstad S, Lawrence D. Varenicline in smokers with diabetes: a pooled analysis of 15 randomized, placebo-controlled studies of varenicline. J Diabetes Investig. 2016; https://doi.org/10.1111/jdi.12543.
Anthonisen NR. Lessons from the lung health study. Proc Am Thorac Soc. 2004;1(2):143–5. https://doi.org/10.1513/pats.2306033.
Burnes D. Chronic obstructive pulmonary disease In: Tobacco: science, policy and public health. Oxford University Press; 2004.
Godtfredsen NS, Lam TH, Hansel TT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J. 2008;32(4):844–53. https://doi.org/10.1183/09031936.00160007.
Hilberink SR, Jacobs JE, Bottema BJ, de Vries H, Grol RP. Smoking cessation in patients with COPD in daily general practice (SMOCC): six months’ results. Prev Med. 2005;41(5–6):822–7. https://doi.org/10.1016/j.ypmed.2005.08.003.
Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783–90. https://doi.org/10.1164/rccm.200511-1746OC.
McLeish AC, Farris SG, Johnson AL, Bernstein JA, Zvolensky MJ. Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: findings from a self-guided quit attempt. Addict Behav. 2016;63:149–54. https://doi.org/10.1016/j.addbeh.2016.07.021.
Perret JL, Bonevski B, McDonald CF, Abramson MJ. Smoking cessation strategies for patients with asthma: improving patient outcomes. J Asthma Allergy. 2016;9:117–28. https://doi.org/10.2147/jaa.s85615.
Balduyck B, Sardari Nia P, Cogen A, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardio-Thorac Surg. 2011;40(6):1432–7.; discussion 1437-8. https://doi.org/10.1016/j.ejcts.2011.03.004.
Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(2):200–11. https://doi.org/10.1177/0194599813490886.
Sheeran P, Jones K, Avishai A, et al. What works in smoking cessation interventions for cancer survivors? A meta-analysis. Health Psychol. 2019;38(10):855–65. https://doi.org/10.1037/hea0000757.
Goldstein AO, Shoenbill KA, Jolly TA. Intensive smoking cessation counseling for patients with cancer. JAMA. 2020;324(14):1401–3. https://doi.org/10.1001/jama.2020.13102.
Park ER, Perez GK, Regan S, et al. Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. JAMA. 2020;324(14):1406–18. https://doi.org/10.1001/jama.2020.14581.
Reddy KP, Parker RA, Losina E, et al. Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: a US-based modeling study. J Infect Dis. 2016;2016 https://doi.org/10.1093/infdis/jiw430.
Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44. https://doi.org/10.7326/m14-0954.
Tseng TY, Krebs P, Schoenthaler A, et al. Combining text messaging and telephone counseling to increase varenicline adherence and smoking abstinence among cigarette smokers living with HIV: a randomized controlled study. AIDS Behav. 2016; https://doi.org/10.1007/s10461-016-1538-z.
Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44. https://doi.org/10.1016/s1055-3290(06)60353-1.
Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS (London, England). 2006;20(2):253–60. https://doi.org/10.1097/01.aids.0000198094.23691.58.
Gfroerer JDS, King BA, Garrett BE, Babb S, McAfee T. Vital signs: currrent cigarette smoking among adults aged ≥18 years with mental illness, United States 2009–2011. MMWR Morb Mortal Wkly Rep. 2013;62:81–7.
Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297–314. 1p following 314. https://doi.org/10.1146/annurev.publhealth.012809.103701.
Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014;348:g1151. https://doi.org/10.1136/bmj.g1151.
Tsoh JY, Chi FW, Mertens JR, Weisner CM. Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug Alcohol Depend. 2011;114(2–3):110–8. https://doi.org/10.1016/j.drugalcdep.2010.09.008.
Kopsaftis Z, van Agteren J, Carson K, O'Loughlin T, Smith B. Smoking cessation in the hospital setting: a systematic review and meta-analysis. Eur Respir J. 2017;50(suppl 61):PA1271. https://doi.org/10.1183/1393003.congress-2017.PA1271.
Iannello J, Levitt MP, Poetter D, et al. Improving inpatient tobacco treatment measures: outcomes through standardized treatment, care coordination, and electronic health record optimization. J Healthc Qual. 2021;43(1):48–58. https://doi.org/10.1097/JHQ.0000000000000251.
Trout S, Ripley-Moffitt C, Meernik C, Greyber J, Goldstein AO. Provider satisfaction with an inpatient tobacco treatment program: results from an inpatient provider survey. Int J General Med. 2017;10:363–9. https://doi.org/10.2147/IJGM.S136965.
Park HY, Choe YR, Oh IJ, et al. Efficacy of an inpatient smoking cessation program at a single regional cancer center: a prospective observational study. Medicine (Baltimore). 2021;100(6):e24745. https://doi.org/10.1097/MD.0000000000024745.
Matuszewski PE, Joseph K, O'Hara NN, DiClemente C, O'Toole RV. Prospective randomized trial on smoking cessation in orthopaedic trauma patients: results from the let’s STOP (smoking in trauma orthopaedic patients) now trial. J Orthop Trauma. 2021;35(7):345–51. https://doi.org/10.1097/BOT.0000000000002028.
Brown RA, Minami H, Hecht J, et al. Sustained care Smoking cessation intervention for individuals hospitalized for psychiatric disorders: the helping HAND 3 randomized clinical trial. JAMA Psychiatry. 2021;78(8):839–47. https://doi.org/10.1001/jamapsychiatry.2021.0707.
See JJH, See KC. Impact of admission diagnosis on the Smoking cessation rate: a brief report from a multi-Centre inpatient smoking cessation programme in Singapore. J Prev Med Public Health. 2020;53(5):381–6. https://doi.org/10.3961/jpmph.20.134.
Thomas D, Abramson MJ, Bonevski B, et al. Integrating smoking cessation into routine care in hospitals—a randomized controlled trial. Addiction. 2016;111(4):714–23. https://doi.org/10.1111/add.13239.
Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the chronic care model in the new millennium. Health Aff (Millwood). 2009;28(1):75–85. https://doi.org/10.1377/hlthaff.28.1.75.
Wagner EH, Bennett SM, Austin BT, Greene SM, Schaefer JK, Vonkorff M. Finding common ground: patient-centeredness and evidence-based chronic illness care. J Altern Complement Med. 2005;11(supplement 1):s-7–s-15.
McCullough A, Fisher M, Goldstein AO, Kramer KD, Ripley-Moffitt C. Smoking as a vital sign: prompts to ask and assess increase cessation counseling. J Am Board Fam Med. 2009;22(6):625–32. https://doi.org/10.3122/jabfm.2009.06.080211.
Theobald M, Botelho RJ, Saccocio SC, Houston TP, McAfee T, Mullins S, Weida TJ. Treating tobacco dependence practice manual, a systems-change approach. Am Acad Fam Phys; 2017.
Whittet MN, Capesius TR, Zook HG, Keller PA. The role of health systems in reducing tobacco dependence. Am J Accountable Care. 2019;7(2):4–11.
Lindson N, Pritchard G, Hong B, Fanshawe TR, Pipe A, Papadakis S. Strategies to improve smoking cessation rates in primary care. Cochrane Database Syst Rev. 2021;9(9):Cd011556. https://doi.org/10.1002/14651858.CD011556.pub2.
Soulakova JN, Tang CY, Leonardo SA, Taliaferro LA. Motivational benefits of social support and behavioural interventions for smoking cessation. J Smok Cessat. 2018;13(4):216–26. https://doi.org/10.1017/jsc.2017.26.
Cohen S, Lichtenstein E. Partner behaviors that support quitting smoking. J Consult Clin Psychol. 1990;58(3):304–9. https://doi.org/10.1037//0022-006x.58.3.304.
Derrick JL, Leonard KE, Homish GG. Perceived partner responsiveness predicts decreases in smoking during the first nine years of marriage. Nicotine Tob Res. 2013;15(9):1528–36. https://doi.org/10.1093/ntr/ntt011.
Christakis NFJ. The collective dynamics of smoking in a large social network. New Engl J Med. 2008;358(21):2248–58.
Ford P, Clifford A, Gussy K, Gartner C. A systematic review of peer-support programs for smoking cessation in disadvantaged groups. Int J Environ Res Public Health. 2013;10(11):5507–22. https://doi.org/10.3390/ijerph10115507.
Goldade K, Des Jarlais D, Everson-Rose SA, et al. Knowing quitters predicts smoking cessation in a homeless population. Am J Health Behav. 2013;37(4):517–24. https://doi.org/10.5993/ajhb.37.4.9.
Ruge J, Ulbricht S, Schumann A, Rumpf HJ, John U, Meyer C. Intention to quit smoking: is the partner's smoking status associated with the smoker's intention to quit? Int J Behav Med. 2008;15(4):328–35. https://doi.org/10.1080/10705500802365607.
vanDellen MR, Boyd SM, Ranby KW, MacKillop J, Lipkus IM. Willingness to provide support for a quit attempt: a study of partners of smokers. J Health Psychol. 2016;21(9):1840–9. https://doi.org/10.1177/1359105314567209.
Falba TA, Sindelar JL. Spousal concordance in health behavior change. Health Serv Res. 2008;43(1 Pt 1):96–116. https://doi.org/10.1111/j.1475-6773.2007.00754.x.
Ruebush E, Mitra S, Meyer C, Sisler L, Goldstein AO. Using a family systems approach to treat tobacco use among Cancer patients. Int J Environ Res Public Health. 2020;17(6) https://doi.org/10.3390/ijerph17062050.
Lobchuk MM, McClement SE, McPherson CJ, Cheang M. Impact of patient smoking behavior on empathic helping by family caregivers in lung cancer. Oncol Nurs Forum. 2012;39(2):E112–21.
Bottorff JL, Robinson CA, Sullivan KM, Smith ML. Continued family smoking after lung cancer diagnosis: the patient’s perspective. Oncol Nurs Forum. 2009;36(3):E126–32. https://doi.org/10.1188/09.ONF.E126-E132.
Robinson CA, Bottorff JL, Smith ML, Sullivan KM. “Just because you’ve got lung cancer doesn’t mean I will”: lung cancer, smoking, and family dynamics. J Fam Nurs. 2010;16(3):282–301. https://doi.org/10.1177/1074840710370747.
Bottorff JL, Robinson CA, Sarbit G, Graham R, Kelly MT, Torchalla I. A motivational, gender-sensitive smoking cessation resource for family members of patients with lung cancer. Oncol Nurs Forum. 2015;42(4):363–70. https://doi.org/10.1188/15.Onf.42-04ap.
Federal Trade Commission Cigarette Report for 2019 (Federal Trade Commission); 2021, pp. 1–35.
Cleveland Clinic. Stress, stress Management, and Smoking. Cleveland Clinic. http://my.clevelandclinic.org/health/healthy_living/hic_Stress_Management_and_Emotional_Health/hic_Stress_Stress_Management_and_Smoking. Accessed 6 Jan 2017.
Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996:511–44.
Gould GS. Patient-centred tobacco management. Drug Alcohol Rev. 2014;33(1):93–8. https://doi.org/10.1111/dar.12082.
Bernstein SL, Toll BA. Ask about smoking, not quitting: a chronic disease approach to assessing and treating tobacco use. Addict Sci Clin Pract. 2019;14(1):29. https://doi.org/10.1186/s13722-019-0159-z.
Toll BA, Rojewski AM, Duncan LR, et al. “Quitting smoking will benefit your health”: the evolution of clinician messaging to encourage tobacco cessation. Clin Cancer Res. 2014;20(2):301–9. https://doi.org/10.1158/1078-0432.ccr-13-2261.
Apodaca TR, Longabaugh R. Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction. 2009;104(5):705–15. https://doi.org/10.1111/j.1360-0443.2009.02527.x.
Heckman CJ, Egleston BL, Hofmann MT. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control. 2010;19(5):410–6. https://doi.org/10.1136/tc.2009.033175.
Cohen DJ, Clark EC, Lawson PJ, Casucci BA, Flocke SA. Identifying teachable moments for health behavior counseling in primary care. Patient Educ Couns. 2011;85(2):e8–15. https://doi.org/10.1016/j.pec.2010.11.009.
Dresler C, Warren GW, Arenberg D, et al. “Teachable moment” interventions in lung cancer: why action matters. J Thorac Oncol. 2018;13(5):603–5. https://doi.org/10.1016/j.jtho.2018.02.020.
Lawson PJ, Flocke SA. Teachable moments for health behavior change: a concept analysis. Patient Educ Couns. 2009;76(1):25–30. https://doi.org/10.1016/j.pec.2008.11.002.
Puleo GE, Borger T, Bowling WR, Burris JL. The state of the science on cancer diagnosis as a “Teachable Moment” for smoking cessation: a scoping review. Nicotine Tob Res. 2021; https://doi.org/10.1093/ntr/ntab139.
Xiang X. Chronic disease diagnosis as a teachable moment for health behavior changes among middle-aged and older adults. J Aging Health. 2016;28(6):995–1015. https://doi.org/10.1177/0898264315614573.
Buchbinder M, Wilbur R, Zuskov D, McLean S, Sleath B. Teachable moments and missed opportunities for smoking cessation counseling in a hospital emergency department: a mixed-methods study of patient-provider communication. BMC Health Serv Res. 2014;14:651. https://doi.org/10.1186/s12913-014-0651-9.
Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106(1):17–27. https://doi.org/10.1002/cncr.21598.
Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015;(3):CD006936. https://doi.org/10.1002/14651858.CD006936.pub3.
Ellerbeck EF, Mahnken JD, Cupertino AP, et al. Effect of varying levels of disease management on smoking cessation: a randomized trial. Ann Intern Med. 2009;150(7):437–46.
Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T. It is possible to help smokers in early motivational stages to quit. The Inter99 study. Prev Med. 2005;40(3):278–84. https://doi.org/10.1016/j.ypmed.2004.06.011.
Tan J, Zhao L, Chen H. A meta-analysis of the effectiveness of gradual versus abrupt smoking cessation. Tob Induc Dis. 2019;17:09. https://doi.org/10.18332/tid/100557.
Lindson N, Klemperer E, Hong B, Ordóñez-Mena JM, Aveyard P. Smoking reduction interventions for smoking cessation. Cochrane Database Syst Rev. 2019;(9) https://doi.org/10.1002/14651858.CD013183.pub2.
Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2004;(4):CD000165. https://doi.org/10.1002/14651858.CD000165.pub2.
Alterman AI, Gariti P, Mulvaney F. Short- and long-term smoking cessation for three levels of intensity of behavioral treatment. Psychol Addict Behav. 2001;15(3):261–4.
Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest. 2004;125(2):435–8. https://doi.org/10.1378/chest.125.2.435.
Barzilai DA, Goodwin MA, Zyzanski SJ, Stange KC. Does health habit counseling affect patient satisfaction? Prev Med. 2001;33(6):595–9. https://doi.org/10.1006/pmed.2001.0931.
Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–20. https://doi.org/10.1016/s0140-6736(16)30272-0.
USPSTF, Krist AH, Davidson KW, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement. JAMA. 2021;325(3):265–79. https://doi.org/10.1001/jama.2020.25019.
National Association for Alcoholism and Drug Abuse Counselors (NAADAC). National certificate in tobacco treatment practice. https://www.naadac.org/NCTTP. Accessed 10 Dec 2021.
American Academy of Family Physicians (AAFP). Tobacco cessation telehealth guide; 2020. https://www.aafp.org/dam/AAFP/documents/patient_care/tobacco/tobacco-cessation-telehealth-guide.pdf. Accessed 02 May 2021.
American Lung Association. Tobacco cessation, telehealth and a pandemic: a changing landscape; 2020. https://www.lung.org/getmedia/83628722-434c-432b-84f4-754b25ea0cce/tobacco-cessation-and-telehealth_final.pdf. Accessed 05 Feb 2021.
Kotsen C, Dilip D, Carter-Harris L, et al. Rapid scaling up of telehealth treatment for tobacco-dependent cancer patients during the COVID-19 outbreak in New York City. Telemed J E Health. 2020;27(1):20–9. https://doi.org/10.1089/tmj.2020.0194.
Mujcic A, Blankers M, Bommele J, et al. The effectiveness of distance-based interventions for smoking cessation and alcohol moderation among cancer survivors: a meta-analysis. Psychooncology. 2020;29(1):49–60. https://doi.org/10.1002/pon.5261.
Shoenbill KA, Newcomer E, Valcourt-Hall C, Baca-Atlas M, Smith CA, Goldstein AO. An analysis of inpatient tobacco use treatment transition to telehealth. Nicotine Tob Res. 2021; https://doi.org/10.1093/ntr/ntab233.
Cantor JH, McBain RK, Pera MF, Bravata DM, Whaley CM. Who is (and is not) receiving telemedicine care during the COVID-19 pandemic. Am J Prev Med. 2021;61(3):434–8. https://doi.org/10.1016/j.amepre.2021.01.030.
Hirko KA, Kerver JM, Ford S, et al. Telehealth in response to the COVID-19 pandemic: implications for rural health disparities. J Am Med Inform Assoc. 2020;27(11):1816–8. https://doi.org/10.1093/jamia/ocaa156.
Arlington Research. Telehealth take-up: the risks and opportunities; Healthcare Report 2021. November 30, 2021. https://media.kasperskycontenthub.com/wp-content/uploads/sites/43/2021/11/22125239/Kaspersky_Healthcare-report-2021_eng.pdf.
Federal Communications Commission. COVID-19 Telehealth Program. Federal Communications Commission. https://www.fcc.gov/covid-19-telehealth-program. Accessed 05 Apr 2021.
HHS invests $8 million to address gaps in rural telehealth through the telehealth broadband pilot program. 01/11/2021, 2021. Accessed 15 Jan 2021. https://www.hhs.gov/about/news/2021/01/11/hhs-invests-8-million-to-address-gaps-in-rural-telehealth-through-telehealth-broadband-pilot.html
Slater JS, Nelson CL, Parks MJ, Ebbert JO. Connecting low-income smokers to tobacco treatment services. Addict Behav. 2016;52:108–14. https://doi.org/10.1016/j.addbeh.2015.10.013.
Darrat I, Tam S, Boulis M, Williams AM. Socioeconomic disparities in patient use of telehealth during the coronavirus disease 2019 surge. JAMA Otolaryngol Head Neck Surg. 2021;147(3):287–95. https://doi.org/10.1001/jamaoto.2020.5161.
Neutze D, Ripley-Moffitt C, Gwynne M, Goldstein AO. The implementation of a tobacco use registry in an academic family practice. J Am Board Fam Med. 2015;28(2):214–21. https://doi.org/10.3122/jabfm.2015.02.140117.
Dowding D, Randell R, Gardner P, et al. Dashboards for improving patient care: review of the literature. Int J Med Inform Feb 2015;84(2):87–100. doi:https://doi.org/10.1016/j.ijmedinf.2014.10.001.
Khairat SS, Dukkipati A, Lauria HA, Bice T, Travers D, Carson SS. The impact of visualization dashboards on quality of care and clinician satisfaction: integrative literature review. JMIR Hum Factors. 2018;5(2):e22. https://doi.org/10.2196/humanfactors.9328.
Centers for Disease Control and Prevention. Best practices for comprehensive tobacco control programs—2014; 2014.
Ripley-Moffitt C, Neutze D, Gwynne M, Goldstein AO. Patient care outcomes of a tobacco use registry in an academic family practice. J Am Board Fam Med. 2015;28(2):205–13. https://doi.org/10.3122/jabfm.2015.02.140121.
Prutzman YM, Wiseman KP, Grady MA, et al. Using digital technologies to reach tobacco users who want to quit: evidence from the National Cancer Institute’s Smokefree.gov initiative. Am J Prev Med. 2021;60(3 Suppl 2):S172–84. https://doi.org/10.1016/j.amepre.2020.08.008.
Kowitt SD, Goldstein AO, Cykert S. A heart healthy intervention improved tobacco screening rates and cessation support in primary care practices. J Prev Dent. 2022;43(3):375–86. https://doi.org/10.1007/s10935-022-00672-5.
Meyer C, Mitra S, Ruebush E, Sisler L, Wang K, Goldstein AO. A lean quality improvement initiative to enhance tobacco use treatment in a cancer hospital. Int J Environ Res Public Health. 2020;17(6) https://doi.org/10.3390/ijerph17062165.
Sisler L, Omofoye O, Paci K, Hadar E, Goldstein AO, Ripley-Moffitt C. Using lean quality improvement tools to increase delivery of evidence-based tobacco use treatment in hospitalized neurosurgical patients. Jt Comm J Qual Patient Saf. 2017;43(12):633–41. https://doi.org/10.1016/j.jcjq.2017.06.012.
Croyle RT, Morgan GD, Fiore MC. Addressing a core gap in cancer care—the NCI moonshot program to help oncology patients stop smoking. N Engl J Med. 2019;380(6):512–5. https://doi.org/10.1056/NEJMp1813913.
Ugalde A, White V, Rankin NM, et al. How can hospitals change practice to better implement smoking cessation interventions? A systematic review. CA Cancer J Clin. 2021; https://doi.org/10.3322/caac.21709.
Wiseman KP, Hauser L, Clark C, et al. An evaluation of the process and quality improvement measures of the University of Virginia Cancer Center Tobacco Treatment Program. Int J Environ Res Public Health. 2020;17(13) https://doi.org/10.3390/ijerph17134707.
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10:CD006611. https://doi.org/10.1002/14651858.CD006611.pub5.
Sadasivam RS, Cutrona SL, Luger TM, et al. Share2Quit: online social Network peer marketing of tobacco cessation systems. Nicotine Tob Res. 2016; https://doi.org/10.1093/ntr/ntw187.
Beard E, Shahab L, Cummings DM, Michie S, West R. New pharmacological agents to aid Smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline? CNS Drugs. 2016;30(10):951–83. https://doi.org/10.1007/s40263-016-0362-3.
National Academies of Sciences E, Medicine. Public health consequences of E-cigarettes. The National Academies Press; 2018. p. 774.
Hartmann-Boyce J, McRobbie H, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021;(9) https://doi.org/10.1002/14651858.CD010216.pub6.
Ibrahim S, Habiballah M, Sayed IE. Efficacy of electronic cigarettes for smoking cessation: a systematic review and meta-analysis. Am J Health Promot. 2021;35(3):442–55. https://doi.org/10.1177/0890117120980289.
Wang RJ, Bhadriraju S, Glantz SA. E-cigarette use and adult cigarette smoking cessation: a meta-analysis. Am J Public Health. 2021;111(2):230–46. https://doi.org/10.2105/ajph.2020.305999.
Harlow AF, Cho J, Tackett AP, et al. Motivations for E-cigarette use and associations with vaping frequency and smoking abstinence among adults who smoke cigarettes in the United States. Drug Alcohol Depend. 2022;238:109583. https://doi.org/10.1016/j.drugalcdep.2022.109583.
Mirbolouk M, Charkhchi P, Kianoush S, et al. Prevalence and distribution of E-cigarette use among U.S. adults: behavioral risk factor surveillance system, 2016. Ann Intern Med. 2018;169(7):429–38. https://doi.org/10.7326/m17-3440.
de Souza IC, de Barros VV, Gomide HP, et al. Mindfulness-based interventions for the treatment of smoking: a systematic literature review. J Altern Complement Med. 2015;21(3):129–40. https://doi.org/10.1089/acm.2013.0471.
Davis JM, Manley AR, Goldberg SB, Smith SS, Jorenby DE. Randomized trial comparing mindfulness training for smokers to a matched control. J Subst Abus Treat. 2014;47(3):213–21. https://doi.org/10.1016/j.jsat.2014.04.005.
Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA, Brewer JA. Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend. 2013;130(1–3):222–9. https://doi.org/10.1016/j.drugalcdep.2012.11.015.
Wen L, Jiang K, Yuan W, Cui W, Li MD. Contribution of variants in CHRNA5/A3/B4 gene cluster on chromosome 15 to tobacco smoking: from genetic association to mechanism. Mol Neurobiol. 2016;53(1):472–84. https://doi.org/10.1007/s12035-014-8997-x.
Bierut LJ, Johnson EO, Saccone NL. A glimpse into the future—personalized medicine for smoking cessation. Neuropharmacology Jan 2014;76(Pt B):592-599. doi:https://doi.org/10.1016/j.neuropharm.2013.09.009.
O'Loughlin J, Sylvestre MP, Labbe A, et al. Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents. PLoS One. 2014;9(12):e115716. https://doi.org/10.1371/journal.pone.0115716.
Office on Smoking and Health NCfCDPaHP. Youth and Tobacco Use. 09/09/2022.
Barrington-Trimis JL, Braymiller JL, Unger JB, et al. Trends in the age of cigarette smoking initiation among young adults in the US from 2002 to 2018. JAMA Netw Open. 2020;3(10):e2019022. https://doi.org/10.1001/jamanetworkopen.2020.19022.
Stanton A, Grimshaw G. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2013;(8):CD003289. https://doi.org/10.1002/14651858.CD003289.pub5.
American Lung Association. N-O-T: Not On Tobacco—proven teen smoking and vaping cessation program. https://www.lung.org/quit-smoking/helping-teens-quit/not-on-tobacco. Accessed 11 Sep 2022.
U.S. Department Health and Human Services. Smokefree Teen. Accessed 09 Sep 2022. https://teen.smokefree.gov.
Mayo Foundation for Medical Education and Research. Mayo Clinic: teen smoking: how to help your teen quit. https://www.mayoclinic.org/healthy-lifestyle/tween-and-teen-health/in-depth/teen-smoking/art-20046474. Accessed 09 Sep 2022.
MD Anderson Cancer Network. How to help your teen quit vaping. https://www.mdanderson.org/publications/focused-on-health/how-to-help-your-teen-quit-vaping.h13-1593780.html. Accessed 09 Sep 2022.
Graham AL, Amato MS, Cha S, Jacobs MA, Bottcher MM, Papandonatos GD. Effectiveness of a vaping cessation text message program among young adult e-cigarette users: a randomized clinical trial. JAMA Intern Med. 2021;181(7):923–30. https://doi.org/10.1001/jamainternmed.2021.1793.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shoenbill, K.A., Byron, M.J., Weiner, A.A., Goldstein, A.O. (2023). Tobacco Use and Dependence. In: Daaleman, T.P., Helton, M.R. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-031-29171-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-29171-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29170-8
Online ISBN: 978-3-031-29171-5
eBook Packages: MedicineMedicine (R0)